Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Montse Muñoz"'
Autor:
Paula Peremiquel-Trillas, Yolanda Benavente, Mayte Martín-Bustamante, Delphine Casabonne, Beatriz Pérez-Gómez, Inés Gómez-Acebo, Anna Oliete-Canela, Marta Diéguez-Rodríguez, Ignasi Tusquets, Pilar Amiano, Lourdes Mengual, Eva Ardanaz, Rocío Capelo, Antonio J. Molina de la Torre, Dolores Salas Trejo, Guillermo Fernández-Tardón, Virginia Lope, José J. Jimenez-Moleon, Rafael Marcos-Gragera, Trinidad Dierssen-Sotos, Mikel Azpiri, Montse Muñoz, Marcela Guevara, Tania Fernández-Villa, Ana Molina-Barceló, Nuria Aragonés, Marina Pollán, Gemma Castaño-Vinyals, Juan Alguacil, Manolis Kogevinas, Silvia de Sanjosé, Laura Costas
Publikováno v:
Environment International, Vol 122, Iss , Pp 389-399 (2019)
Background: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compou
Externí odkaz:
https://doaj.org/article/8fa1a8787ee241ebaa07dd2cc2ea6ca3
Autor:
Vanessa Almendro, Yu-Kang Cheng, Amanda Randles, Shalev Itzkovitz, Andriy Marusyk, Elisabet Ametller, Xavier Gonzalez-Farre, Montse Muñoz, Hege G. Russnes, Åslaug Helland, Inga H. Rye, Anne-Lise Borresen-Dale, Reo Maruyama, Alexander van Oudenaarden, Mitchell Dowsett, Robin L. Jones, Jorge Reis-Filho, Pere Gascon, Mithat Gönen, Franziska Michor, Kornelia Polyak
Publikováno v:
Cell Reports, Vol 6, Iss 3, Pp 514-527 (2014)
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of how tumors change during treatment is limited. Here, we report the analysis of cellular heterogeneity for genetic and phenotypic features and their sp
Externí odkaz:
https://doaj.org/article/9aab389303f9453b895d7dc845938253
Autor:
Inés Gómez-Acebo, Trinidad Dierssen-Sotos, Camilo Palazuelos, Beatriz Pérez-Gómez, Virginia Lope, Ignasi Tusquets, M Henar Alonso, Victor Moreno, Pilar Amiano, Antonio José Molina de la Torre, Aurelio Barricarte, Adonina Tardon, Antonio Camacho, Rosana Peiro-Perez, Rafael Marcos-Gragera, Montse Muñoz, Maria Jesus Michelena-Echeveste, Luis Ortega Valin, Marcela Guevara, Gemma Castaño-Vinyals, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Javier Llorca
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159672 (2016)
The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased r
Externí odkaz:
https://doaj.org/article/4d6bee4352114fcba6f72ea89c0a406e
Autor:
Xavier Guardia, Garazi Serna, J. Cortés, Begoña Bermejo, Roberta Fasani, Patricia Galván, Gaia Griguolo, Nuria Chic, Luis Manso, Serafin Morales, N. Martínez, I Garau, Maria Vidal, Montse Muñoz, Antonio Llombart-Cussac, Mafalda Oliveira, Paolo Nuciforo, Aleix Prat, Laia Paré, Patricia Villagrasa, E Martínez, Sonia Pernas, J. Alarcón, Tomás Pascual, Ramon Lopez
Publikováno v:
Scientia
npj Precision Oncology, Vol 5, Iss 1, Pp 1-12 (2021)
npj Precision Oncology
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
NPJ Precision Oncology
Dipòsit Digital de la UB
Universidad de Barcelona
npj Precision Oncology, Vol 5, Iss 1, Pp 1-12 (2021)
npj Precision Oncology
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
NPJ Precision Oncology
Dipòsit Digital de la UB
Universidad de Barcelona
Taca de plasma sec; Hepatitis C; Targeta de separació de plasma Mancha de plasma seco; Hepatitis C; Tarjeta de separación de plasma Dried plasma spot; Hepatitis C; Plasma separation card Despite their recognised role in HER2-positive (HER2+) breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1fdf40b010ab233d3dd68511f1fed0a
https://hdl.handle.net/11351/6546
https://hdl.handle.net/11351/6546
Autor:
Serafin Morales, Roberta Fasani, J. Alarcón, I Garau, T. Pascual, E Martínez, Begoña Bermejo, Noelia Martínez, Patricia Villagrasa, Paolo Nuciforo, Luis Manso, Aleix Prat, Maria Vidal, Montse Muñoz, Gaia Griguolo, Esther Holgado, Laia Paré, Marcos Vinicius Silva Oliveira, Ramon Lopez, Sonia Pernas, Patricia Galván, Antonio Llombart-Cussac, J. Cortes
Publikováno v:
Cancer Research. 79:P6-17
Background: TILs in HER2+ breast cancer (BC) predict 1) prognosis in early setting, 2) complete pathological response (pCR) following neoadjuvant antiHER2-based therapy and 3) response to trastuzumab and pembrolizumab in the metastatic setting. Howev
Autor:
J. Cortes, Manuel Ruiz-Borrego, J de la Haba, Federico Rojo, Nuria Chic, T. Pascual, Aleix Prat, Rachel Schiff, Blanca Gonzalez-Farre, Valentina Guarneri, Pierfranco Conte, M. Martin, E. Alba, Patricia Galván, B. Adamo, A. Lluch, Joel S. Parker, Maria Vidal, Mothaffar F. Rimawi, Montse Muñoz, A Sullivan, Antonio Llombart, HA Brauer, Paolo Nuciforo, Laia Paré, YS Tsai
Publikováno v:
Cancer Research. 79:P2-08
Background: The expression of ER, PR and HER2 in breast cancer is determined by routine pathology assessment to indicate systemic treatment. Here, we investigated the ability of a standardized mRNA-based assay to predict ER, PR and HER2 status and tr
Autor:
Nuria Chic, Luis Manso, C Pernaut, T. Pascual, Eva Ciruelos, Maria Vidal, Montse Muñoz, Patricia Galván, Patricia Villagrasa, B. Adamo, P. Tolosa, Marta Dueñas, Blanca Gonzalez-Farre, Aleix Prat, C Bárcena
Publikováno v:
Cancer Research. 79:P2-08
Background: The TIS is a clinical research gene expression-based assay that enriches for response to anti-PD1 monotherapy in multiple cancer-types (Ayers et al. JCI 2017). However, the expression of the TIS in mTNBC and its relationship with other bi
Autor:
Begoña Bermejo, T. Pascual, Patricia Villagrasa, Fara Brasó-Maristany, Maria Vidal, Montse Muñoz, Laia Paré, J. Cortes, Marcos Vinicius Silva Oliveira, Noelia Martínez, Patricia Galván, Luis Manso, Antonio Llombart-Cussac, Ramon Lopez, Sonia Pernas, Aleix Prat, Gaia Griguolo, Serafin Morales, I Garau, E Martínez, J. Alarcón
Publikováno v:
Cancer Research. 79:P6-17
Background: HER2-positive (HER2+) breast cancer (BC) is composed of 4 molecular subtypes: Luminal A and B, HER2-enriched (HER2-E) and Basal-like. Among them, the HER2-E is highly sensitive to anti-HER2 treatment. However, ˜60% of HER2-E tumors do no
Autor:
R. Wolman, Montse Muñoz, Martina Alvarez, Sara Gil, J. Alcaide-Garcia, C. Reyna, Gema Durán, Iris Faull, E. Torres, Emiliano Zamora de Alba, M. Benavides, M. Kushnir
Publikováno v:
Annals of Oncology. 32:S578-S579
Autor:
Lourdes Calvo, Miguel Gil-Gil, Emiliano Zamora de Alba, Antonio Antón, J. de la Haba, M. Martin Jimenez, E.M. Ciruelos, M. Ramos, Nicholas C. Turner, Mireia Margeli, Begoña Bermejo, Massimo Corsaro, Montse Muñoz, Tibor Csoszi, Manuel Ruiz-Borrego, Zsuzsanna Kahán, Miquel Casas, Christoph C. Zielinski, Serafin Morales, Eva Carrasco
Publikováno v:
Annals of Oncology. 32:S457-S458